Cargando…

Transforming Growth Factor-β2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Other Phenotypic Cell Surface Markers

Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered, however, by recipient immune recognition and rejection of major histocompatibility complex (MHC)-mismatched MSCs. Development o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berglund, Alix K., Fisher, Matthew B., Cameron, Kristin A., Poole, Emma J., Schnabel, Lauren V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466990/ https://www.ncbi.nlm.nih.gov/pubmed/28660198 http://dx.doi.org/10.3389/fvets.2017.00084

Ejemplares similares

TGF-β2 Reduces the Cell-Mediated Immunogenicity of Equine MHC-Mismatched Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Immunomodulatory Properties
por: Berglund, Alix K., et al.
Publicado: (2021)

The immunomodulation–immunogenicity balance of equine Mesenchymal Stem Cells (MSCs) is differentially affected by the immune cell response depending on inflammatory licensing and major histocompatibility complex (MHC) compatibility
por: Cequier, Alina, et al.
Publicado: (2022)

Allogeneic major histocompatibility complex‐mismatched equine bone marrow‐derived mesenchymal stem cells are targeted for death by cytotoxic anti‐major histocompatibility complex antibodies
por: Berglund, A.K., et al.
Publicado: (2016)

T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen
Publicado: (1993)

Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells
Publicado: (1984)

Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro
por: Schnabel, Lauren V, et al.
Publicado: (2014)

Major Histocompatibility Complex (MHC) Markers in Conservation Biology
por: Ujvari, Beata, et al.
Publicado: (2011)

The Major Histocompatibility Complex (MHC) in Schizophrenia: A Review
por: Mokhtari, Ryan, et al.
Publicado: (2016)

Comparative Genomics of the Major Histocompatibility Complex (MHC) of Felids
por: Plasil, Martin, et al.
Publicado: (2022)

Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection
Publicado: (1992)

High-Resolution Genotyping of Expressed Equine MHC Reveals a Highly Complex MHC Structure
por: Vasoya, Deepali, et al.
Publicado: (2023)

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
por: Wieczorek, Marek, et al.
Publicado: (2017)

TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens
por: Akatsuka, Yoshiki
Publicado: (2020)

Force Measurements of TCR/pMHC Recognition at T Cell Surface
por: Puech, Pierre-Henri, et al.
Publicado: (2011)

Major Histocompatibility Complex (MHC) Genes and Disease Resistance in Fish
por: Yamaguchi, Takuya, et al.
Publicado: (2019)

Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the alpha 2 and alpha 3 domains of MHC class I
Publicado: (1995)

Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro
por: Sherman, Amanda B., et al.
Publicado: (2017)

The V beta complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex
Publicado: (1994)

Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation
Publicado: (1992)

Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation
por: Delamarre, Lélia, et al.
Publicado: (2003)

Recent advances in Major Histocompatibility Complex (MHC) class I antigen presentation: Plastic MHC molecules and TAPBPR-mediated quality control
por: van Hateren, Andy, et al.
Publicado: (2017)

The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
por: Caron, Etienne, et al.
Publicado: (2011)

Homotypic and heterotypic in cis associations of MHC class I molecules at the cell surface
por: Ruggiero, Fernando M., et al.
Publicado: (2022)

MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells
por: Silva, Zélia, et al.
Publicado: (2020)

Major histocompatibility complex (MHC) associations with diseases in ethnic groups of the Arabian Peninsula
por: Al Naqbi, Halima, et al.
Publicado: (2021)

PredMHC: An Effective Predictor of Major Histocompatibility Complex Using Mixed Features
por: Chen, Dong, et al.
Publicado: (2022)

Major Histocompatibility Complex (MHC) Diversity of the Reintroduction Populations of Endangered Przewalski’s Horse
por: Tang, Yongqing, et al.
Publicado: (2022)

The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation
por: Carapito, Raphael, et al.
Publicado: (2022)

PGG.MHC: toward understanding the diversity of major histocompatibility complexes in human populations
por: Zhao, Xiaohan, et al.
Publicado: (2022)

The mode of action of tapasin on major histocompatibility class I (MHC-I) molecules
por: Lan, By Huan, et al.
Publicado: (2023)

Analysis of cross-reactive antigen-specific T cell clones. Specific recognition of two major histocompatibility complex (MHC) and two non- MHC antigens by a single clone
Publicado: (1983)

NK cell education via nonclassical MHC and non-MHC ligands
por: He, Yuke, et al.
Publicado: (2017)

Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
por: Taylor, Brandie C., et al.
Publicado: (2022)

Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes
Publicado: (1992)

Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases
Publicado: (1995)

Imbalanced MHC class II molecule expression at surface of murine B cell lymphomas
Publicado: (1986)

Expression of Class I and II Major Histocompatibility Complex (MHC) Antigens in the Developing CNS
por: Grabowska, A., et al.
Publicado: (1992)

A genome-wide survey of Major Histocompatibility Complex (MHC) genes and their paralogues in zebrafish
por: Sambrook, Jennifer G, et al.
Publicado: (2005)

Red Queen Processes Drive Positive Selection on Major Histocompatibility Complex (MHC) Genes
por: Ejsmond, Maciej Jan, et al.
Publicado: (2015)

Inter- and intrabreed diversity of the major histocompatibility complex (MHC) in primitive and draft horse breeds
por: Jaworska, Joanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fh6hilpd4gj28ogg1dodkpmdu3